Lu Xie, MD

Lu Xie, MD, discusses the design of the phase 2 ARTEMIS-002 trial.

Lu Xie, MD, discusses the scientific rationale and clinical development strategy for HS-20093 in the phase 2 ARTEMIS-002 trial.